Maritime transportation company Matson (NYSE:MATX) missed Wall Street’s revenue expectations in Q1 CY2025, but sales rose 8.3% year on year to $782 million. Its GAAP profit of $2.18 per share was 3.8% below analysts’ consensus estimates. Is now the time to buy Matson? Find …
Inspire Medical Systems (INSP) came out with quarterly earnings of $0.10 per share, beating the Zacks Consensus Estimate of a loss of $0.23 per share. This compares to loss of $0.34 per share a year ago. These figures are adjusted for non-recurring items. This …
Neurocrine Biosciences (NBIX) came out with quarterly earnings of $0.08 per share, missing the Zacks Consensus Estimate of $0.43 per share. This compares to earnings of $0.42 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an …
HOUSTON, TX / ACCESS Newswire / May 5, 2025 / PATTERSON-UTI ENERGY, INC. (NASDAQ:PTEN) today reported that for the month of April 2025, the Company had an average of 108 drilling rigs operating in the United States. Average drilling rigs operating reported in the …
TORONTO, May 05, 2025 (GLOBE NEWSWIRE) -- Timbercreek Financial (TSX: TF) (the “Company”) announced today its financial results for the three months ended March 31, 2025 (“Q1 2025”). Q1 2025 Highlights1 Strong top-line income and distributable income: Net investment income of $28.6 million compared …
We recently published a list of Jim Cramer’s Thoughts on These 13 Stocks. In this article, we are going to take a look at where Viemed Healthcare, Inc. (NASDAQ:VMD) stands against other stocks that Jim Cramer discussed. On Thursday’s episode of Mad Money, Jim …
We recently published a list of Jim Cramer’s Thoughts on These 13 Stocks. In this article, we are going to take a look at where Tempus AI, Inc. (NASDAQ:TEM) stands against other stocks that Jim Cramer discussed. On Thursday’s episode of Mad Money, Jim …
We recently published a list of Jim Cramer’s Thoughts on These 13 Stocks. In this article, we are going to take a look at where C3.ai, Inc. (NYSE:AI) stands against other stocks that Jim Cramer discussed. On Thursday’s episode of Mad Money, Jim Cramer …
The S&P 500 and the Dow Jones Industrial Average snapped their nine-day winning streak as traders ev PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premium news articles. Upgrade …
Biopharma company Corcept Therapeutics (NASDAQ:CORT) missed Wall Street’s revenue expectations in Q1 CY2025, but sales rose 7.1% year on year to $157.2 million. On the other hand, the company’s full-year revenue guidance of $925 million at the midpoint came in 2.2% above analysts’ estimates. …